Urea Cycle Disorder Equipment In USA
1 equipment items found
-
based in USA
Selecta’s wholly owned gene therapy program for the treatment of ornithine transcarbamylase (OTC) deficiency is expected to enter the clinic in 2022. OTC deficiency is a genetic disorder urea cycle that causes ammonia to accumulate in the blood. The most severe form of the disorder presents within the first few days of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you